Abbott cuts 2026 sales growth view, plans to spin off nutrition business
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Abbott cuts 2026 sales growth view, plans to spin off nutrition business" is generating significant coverage in the Business category, with 1 articles from 1 distinct sources tracked by PULSE so far.
Outlets currently covering the story include Yahoo Finance. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 11h ago.
Quick answers
Why is "Abbott cuts 2026 sales growth view, plans to spin off nutrition business" trending?
Because 1 independent news sources published 1 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (1)
- Abbott Reports Third-Quarter 2026 Results and Reaffirms Full-Year EPS Guidance Yahoo Finance · 16h ago
Topics
Related trends
‘Abbott Elementary’ Season 6 Premiere Hits 6.3 Million Viewers in Seven Days (EXCLUSIVE)
5 news sources are covering this Entertainment story right now — PULSE is tracking how fast it spreads.
Abbott to Carve Out Nutrition Business Into Independent Company
Abbott plans to spin off its nutrition business into a separate publicly traded company while cutting its 2026 sales growth outlook.
Abbott to Pay $670 Million to Settle Baby-Formula Litigation
Abbott Laboratories agrees to pay $670 million to resolve thousands of preterm infant formula lawsuits.
X-Men: Christopher Abbott and Sadie Sink in new Marvel movie
Marvel reveals a star-studded cast for its X-Men reboot, featuring Sadie Sink and Christopher Abbott with a scheduled May 2028 release.
Abbott Reports Second-Quarter 2026 Results and Raises Full-Year EPS Guidance
Abbott Laboratories boosts its 2026 full-year profit guidance after reporting stronger-than-expected second-quarter sales and earnings.
When Is the Best Time to Take Creatine?
16 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.